ERO:PA:PA-SPDR MSCI Europe UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 308.044

Change

-0.20 (-0.06)%

Market Cap

USD 0.26B

Volume

7.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.26 (+0.59%)

USD 63.50B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+2.00 (+0.38%)

USD 12.35B
WRD:PA HSBC ETFs Public Limited Compa..

+0.15 (+0.44%)

USD 10.45B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.26 (+0.11%)

USD 8.60B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+2.10 (+0.47%)

USD 8.12B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.63 (+0.48%)

USD 7.00B
HHH:PA HSBC ETFs Public Limited Compa..

+0.26 (+0.49%)

USD 6.90B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.08 (+0.47%)

USD 6.43B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+2.06 (+0.55%)

USD 5.51B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.81 (+0.53%)

USD 4.88B

ETFs Containing ERO:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.26% 50% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.26% 50% F 64% D
Trailing 12 Months  
Capital Gain 17.93% 54% F 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.93% 54% F 66% D+
Trailing 5 Years  
Capital Gain 41.79% 62% D 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.79% 62% D 73% C
Average Annual (5 Year Horizon)  
Capital Gain 11.37% 67% D+ 67% D+
Dividend Return 11.37% 67% D+ 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.93% 53% F 74% C
Risk Adjusted Return 87.96% 79% B- 88% B+
Market Capitalization 0.26B 51% F 61% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike